Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 2 July 1999:
Vol. 285. no. 5424, pp. 26 - 30
DOI: 10.1126/science.285.5424.26
Prev | Table of Contents | Next

News Focus

The Scientific Challenge of Hepatitis C

Jon Cohen

The hepatitis C virus (HCV) infects some 170 million people worldwide--more than four times as many as HIV--and is causing rising rates of liver disease. Like HIV, it is a wily foe for researchers developing drugs and vaccines, because HCV also mutates rapidly, creating a swarm of different viruses in each infected person that can thwart antibodies easily. But progress is beginning to be made: Although to date no one has been able to grow HCV reliably in a laboratory culture of cells, on page 110, researchers describe a new system for culturing HCV's RNA. And a study on page 107 offers one possible explanation for why some HCV strains are more resistant to interferon, the standard treatment for HCV, than others.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Phenotypic and Functional Changes of Cytotoxic CD56pos Natural T Cells Determine Outcome of Acute Hepatitis C Virus Infection.
L. Golden-Mason, N. Castelblanco, C. O'Farrelly, and H. R. Rosen (2007)
J. Virol. 81, 9292-9298
   Abstract »    Full Text »    PDF »
Evolution of Resistant M414T Mutants among Hepatitis C Virus Replicon Cells Treated with Polymerase Inhibitor A-782759.
L. Lu, H. Mo, T. J. Pilot-Matias, and A. Molla (2007)
Antimicrob. Agents Chemother. 51, 1889-1896
   Abstract »    Full Text »    PDF »
Hepatitis C virus infection, cryoglobulinaemia, and beyond.
D. Sansonno, A. Carbone, V. De Re, and F. Dammacco (2007)
Rheumatology 46, 572-578
   Abstract »    Full Text »    PDF »
Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses..
M. Vajdy, M. Selby, A. Medina-Selby, D. Coit, J. Hall, L. Tandeske, D. Chien, C. Hu, D. Rosa, M. Singh, et al. (2006)
J. Gen. Virol. 87, 2253-2262
   Abstract »    Full Text »    PDF »
Broad Repertoire of the CD4+ Th Cell Response in Spontaneously Controlled Hepatitis C Virus Infection Includes Dominant and Highly Promiscuous Epitopes.
J. Schulze zur Wiesch, G. M. Lauer, C. L. Day, A. Y. Kim, K. Ouchi, J. E. Duncan, A. G. Wurcel, J. Timm, A. M. Jones, B. Mothe, et al. (2005)
J. Immunol. 175, 3603-3613
   Abstract »    Full Text »    PDF »
Interdomain Communication in Hepatitis C Virus Polymerase Abolished by Small Molecule Inhibitors Bound to a Novel Allosteric Site.
S. Di Marco, C. Volpari, L. Tomei, S. Altamura, S. Harper, F. Narjes, U. Koch, M. Rowley, R. De Francesco, G. Migliaccio, et al. (2005)
J. Biol. Chem. 280, 29765-29770
   Abstract »    Full Text »    PDF »
Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2.
T. Naas, M. Ghorbani, I. Alvarez-Maya, M. Lapner, R. Kothary, Y. De Repentigny, S. Gomes, L. Babiuk, A. Giulivi, C. Soare, et al. (2005)
J. Gen. Virol. 86, 2185-2196
   Abstract »    Full Text »    PDF »
Molecular Epidemiology of Hepatitis C Virus Genotype 4 Isolates in Egypt and Analysis of the Variability of Envelope Proteins E1 and E2 in Patients with Chronic Hepatitis.
D. Genovese, S. Dettori, C. Argentini, U. Villano, P. Chionne, M. Angelico, and M. Rapicetta (2005)
J. Clin. Microbiol. 43, 1902-1909
   Abstract »    Full Text »    PDF »
Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells.
T. N. Q. Pham, S. A. MacParland, C. S. Coffin, S. S. Lee, F. R. Bursey, and T. I. Michalak (2005)
J. Gen. Virol. 86, 657-666
   Abstract »    Full Text »    PDF »
Structural characterization of the highly conserved 98-base sequence at the 3' end of HCV RNA genome and the complementary sequence located at the 5' end of the replicative viral strand.
M. Dutkiewicz and J. Ciesiolka (2005)
Nucleic Acids Res. 33, 693-703
   Abstract »    Full Text »    PDF »
Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes.
X. Jiao, R. Y.-H. Wang, Q. Qiu, H. J. Alter, and J. W.-K. Shih (2004)
J. Gen. Virol. 85, 1545-1553
   Abstract »    Full Text »    PDF »
Hepatitis C Virus Persistence after Spontaneous or Treatment-Induced Resolution of Hepatitis C.
T. N. Q. Pham, S. A. MacParland, P. M. Mulrooney, H. Cooksley, N. V. Naoumov, and T. I. Michalak (2004)
J. Virol. 78, 5867-5874
   Abstract »    Full Text »    PDF »
The N-terminal half of the core protein of hepatitis C virus is sufficient for nucleocapsid formation.
N. Majeau, V. Gagne, A. Boivin, M. Bolduc, J.-A. Majeau, D. Ouellet, and D. Leclerc (2004)
J. Gen. Virol. 85, 971-981
   Abstract »    Full Text »    PDF »
High-Resolution Phylogenetic Analysis of Hepatitis C Virus Adaptation and Its Relationship to Disease Progression.
I. Sheridan, O. G. Pybus, E. C. Holmes, and P. Klenerman (2004)
J. Virol. 78, 3447-3454
   Abstract »    Full Text »    PDF »
Identification of a C-Terminal Regulatory Motif in Hepatitis C Virus RNA-Dependent RNA Polymerase: Structural and Biochemical Analysis.
V. J.-P. Leveque, R. B. Johnson, S. Parsons, J. Ren, C. Xie, F. Zhang, and Q. M. Wang (2003)
J. Virol. 77, 9020-9028
   Abstract »    Full Text »    PDF »
Characterization of secreted and intracellular forms of a truncated hepatitis C virus E2 protein expressed by a recombinant herpes simplex virus.
M. Lucas, E. Tsitoura, M. Montoya, B. Laliotou, E. Aslanoglou, V. Kouvatsis, C. Entwisle, J. Miller, P. Klenerman, A. Hadziyannis, et al. (2003)
J. Gen. Virol. 84, 545-554
   Abstract »    Full Text »    PDF »
Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection.
C. L. Day, G. M. Lauer, G. K. Robbins, B. McGovern, A. G. Wurcel, R. T. Gandhi, R. T. Chung, and B. D. Walker (2002)
J. Virol. 76, 12584-12595
   Abstract »    Full Text »    PDF »
Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees.
J. Bukh, T. Pietschmann, V. Lohmann, N. Krieger, K. Faulk, R. E. Engle, S. Govindarajan, M. Shapiro, M. St. Claire, and R. Bartenschlager (2002)
PNAS 99, 14416-14421
   Abstract »    Full Text »    PDF »
Evolution of Epitope-Specific Memory CD4+ T Cells After Clearance of Hepatitis C Virus.
A. J. Godkin, H. C. Thomas, and P. J. Openshaw (2002)
J. Immunol. 169, 2210-2214
   Abstract »    Full Text »    PDF »
A Collaborative Screening Program for the Discovery of Inhibitors of HCV NS2/3 cis-Cleaving Protease Activity.
M. Whitney, J. H. Stack, P. L. Darke, W. Zheng, J. Terzo, J. Inglese, B. Strulovicil, L. C. Kuo, and B. A. Pollok (2002)
J Biomol Screen 7, 149-154
   Abstract »    PDF »
Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?.
A K Burroughs, R Groszmann, J Bosch, N Grace, G Garcia-Tsao, D Patch, J C Garcia-Pagan, and L Dagher (2002)
Gut 50, 425-427
   Abstract »    Full Text »    PDF »
Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles.
C. Brinster, M. Chen, D. Boucreux, G. Paranhos-Baccala, P. Liljestrom, F. Lemmonier, and G. Inchauspe (2002)
J. Gen. Virol. 83, 369-381
   Abstract »    Full Text »    PDF »
Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions.
C.-T. K. Tseng and G. R. Klimpel (2001)
J. Exp. Med. 195, 43-50
   Abstract »    Full Text »    PDF »
Design, high-level expression, purification and characterization of soluble fragments of the hepatitis C virus NS3 RNA helicase suitable for NMR-based drug discovery methods and mechanistic studies.
J. J. Gesell, D. Liu, V. S. Madison, T. Hesson, Y.-S. Wang, P. C. Weber, and D. F. Wyss (2001)
Protein Eng. Des. Sel. 14, 573-582
   Abstract »    Full Text »    PDF »
Molecular Characterization of B Cell Clonal Expansions in the Liver of Chronically Hepatitis C Virus-Infected Patients.
V. Racanelli, D. Sansonno, C. Piccoli, F. P. D'Amore, F. A. Tucci, and F. Dammacco (2001)
J. Immunol. 167, 21-29
   Abstract »    Full Text »    PDF »
Antigenicity and Immunogenicity of Novel Chimeric Hepatitis B Surface Antigen Particles with Exposed Hepatitis C Virus Epitopes.
H. J. Netter, T. B. Macnaughton, W.-P. Woo, R. Tindle, and E. J. Gowans (2001)
J. Virol. 75, 2130-2141
   Abstract »    Full Text »    PDF »
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine.
N. K. Polakos, D. Drane, J. Cox, P. Ng, M. J. Selby, D. Chien, D. T. O'Hagan, M. Houghton, and X. Paliard (2001)
J. Immunol. 166, 3589-3598
   Abstract »    Full Text »    PDF »
Transmission of Hepatitis C Virus from a Patient to an Anesthesiology Assistant to Five Patients.
R. S. Ross, S. Viazov, T. Gross, F. Hofmann, H.-M. Seipp, and M. Roggendorf (2000)
N. Engl. J. Med. 343, 1851-1854
   Full Text »    PDF »
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus.
F. Lechner, D. K.H. Wong, P. R. Dunbar, R. Chapman, R. T. Chung, P. Dohrenwend, G. Robbins, R. Phillips, P. Klenerman, and B. D. Walker (2000)
J. Exp. Med. 191, 1499-1512
   Abstract »    Full Text »    PDF »
Human Immunodeficiency Virus and Hepatitis C Virus Infections among Patients Attending Sexually Transmitted Disease Clinics, Regional 2, Thai land.
P. Luksamijarulkul, P. Khemnak, and O. Pacheun (2000)
Asia Pac J Public Health 12, 41-45
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)